Jan 13, 2021 / 03:50PM GMT
Eric William Joseph - JPMorgan Chase & Co, Research Division - VP & Senior Analyst
Good morning, and thanks again for tuning into the JPMorgan Healthcare Conference. I'm Eric Joseph, senior biotech analyst. Our next presenting company is Omeros, and it's my pleasure to welcome CEO, Greg Demopulos, to tell us a little bit about the company.
Just a programming note, there is a Q&A after the presentation. Please feel free to submit questions by clicking the Ask A Question button, and I'll offer those on your behalf.
With that, Greg, thank you so much for sharing some of your time with us.
Gregory A. Demopulos - Omeros Corporation - Co-Founder, Chairman, CEO & President
Thanks, Eric. Appreciate it. Good morning, everyone, and happy new year. We appreciate the opportunity to participate in the JPMorgan conference.
As you know, there will be forward-looking statements in this presentation. So I refer you to our latest 10-Q filing.
We're going to be going through a good deal of information today. Since we are all
Omeros Corp at JPMorgan Healthcare Conference (Virtual) Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot